nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1
|
Zheng, Ze |
|
|
133 |
7 |
p. 743-753 |
artikel |
2 |
Editorial Board
|
|
|
|
133 |
7 |
p. i |
artikel |
3 |
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
|
Sterner, Rosalie M. |
|
|
133 |
7 |
p. 697-709 |
artikel |
4 |
Hepatocyte tPA: where have you been hiding?
|
Gonias, Steven L. |
|
|
133 |
7 |
p. 631-632 |
artikel |
5 |
IDH2 inhibition: another piece to the puzzle
|
Bullinger, Lars |
|
|
133 |
7 |
p. 625-626 |
artikel |
6 |
Imaging in multiple myeloma: How? When?
|
Zamagni, Elena |
|
|
133 |
7 |
p. 644-651 |
artikel |
7 |
Intraocular toxoplasmosis mimicking vitreous lymphoma
|
Su, Ruijun Jeanna |
|
|
133 |
7 |
p. 767 |
artikel |
8 |
Introduction to a review series on advances in multiple myeloma
|
Avet-Loiseau, Hervé |
|
|
133 |
7 |
p. 621 |
artikel |
9 |
Low-dose chidamide restores immune tolerance in ITP in mice and humans
|
Zhao, Hong-yu |
|
|
133 |
7 |
p. 730-742 |
artikel |
10 |
Megakaryocytes and platelets from a novel human adipose tissue–derived mesenchymal stem cell line
|
Tozawa, Keiichi |
|
|
133 |
7 |
p. 633-643 |
artikel |
11 |
Megakaryocytes from fat: a new recipe for platelets
|
Balduini, Alessandra |
|
|
133 |
7 |
p. 623-625 |
artikel |
12 |
Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin
|
Efentakis, Panagiotis |
|
|
133 |
7 |
p. 710-723 |
artikel |
13 |
Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
|
Stein, Eytan M. |
|
|
133 |
7 |
p. 676-687 |
artikel |
14 |
More than one pathway: novel treatment for ITP
|
Neunert, Cindy E. |
|
|
133 |
7 |
p. 629-630 |
artikel |
15 |
Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics
|
Qian, Maoxiang |
|
|
133 |
7 |
p. 724-729 |
artikel |
16 |
Off-target effects of carfilzomib that cause cardiotoxicity
|
Moreb, Jan S. |
|
|
133 |
7 |
p. 626-628 |
artikel |
17 |
Porpaczy E, Tripolt S, Hoelbl-Kovacic A, et al. Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy. Blood. 2018;132(7):694-706.
|
|
|
|
133 |
7 |
p. 768 |
artikel |
18 |
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing
|
Kumar, Shaji K. |
|
|
133 |
7 |
p. 652-659 |
artikel |
19 |
Serial transplantation reveals a critical role for endoglin in hematopoietic stem cell quiescence
|
Borges, Luciene |
|
|
133 |
7 |
p. 688-696 |
artikel |
20 |
Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay
|
Muchtar, Eli |
|
|
133 |
7 |
p. 763-766 |
artikel |
21 |
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases
|
Thakar, Monica S. |
|
|
133 |
7 |
p. 754-762 |
artikel |
22 |
Toward personalized treatment in multiple myeloma based on molecular characteristics
|
Pawlyn, Charlotte |
|
|
133 |
7 |
p. 660-675 |
artikel |
23 |
Yet another susceptibility variant for ALL: what's next?
|
Schmiegelow, Kjeld |
|
|
133 |
7 |
p. 628-629 |
artikel |